COVISCORE

Serial Number 88916800
606

Registration Progress

Application Filed
May 14, 2020
Under Examination
Jun 29, 2021
Approved for Publication
May 4, 2021
Published for Opposition
May 4, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: COVISCORE
Previous Owner: NanoMosaic L.L.C.
Classes: 005, 042, 044

Trademark Image

COVISCORE

Basic Information

Serial Number
88916800
Filing Date
May 14, 2020
Published for Opposition
May 4, 2021
Abandonment Date
August 5, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 5, 2024
Classes
005 042 044

Rights Holder

NanoMosaic L.L.C.

16
Address
12 Gill Street, Suite 4200
Woburn, MA 01801

Ownership History

NanoMosaic L.L.C.

Original Applicant
16
Woburn, MA

NanoMosaic L.L.C.

Owner at Publication
16
Woburn, MA

Legal Representation

Attorney
Bruce W. Baber

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

45 events
Date Code Type Description Documents
Aug 5, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 5, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 19, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 26, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 16, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 28, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 31, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 29, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 29, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 1, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 29, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 29, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 28, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 28, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 28, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 29, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 4, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 4, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 14, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 29, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 29, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 29, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 29, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 29, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 29, 2021 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Mar 23, 2021 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Mar 7, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 6, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 5, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 12, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 28, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 18, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic tests and kits comprised of medical diagnostic reagents, assays and materials; medical diagnostic reagents, assays and materials for testing; all of the foregoing related to the diagnosis and treatment of COVID-19 and other coronavirus diseases
Class 042
Research, design and development of diagnostic tests and kits comprised of medical diagnostic reagents, assays and materials; all of the foregoing related to the diagnosis and treatment of COVID-19 and other coronavirus diseases
Class 044
Medical diagnostic testing, monitoring and reporting services related to the treatment of COVID-19;  providing medical testing and diagnostic services for others, namely, conducting tests and reporting test results

Classification

International Classes
005 042 044